Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...

For the first time, an individual has been seen publicly controlling an iPad entirely through thought, thanks to Apple's new brain-computer interface (BCI) protocol and Synchron's implantable ...

Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...